Approximately half of the people with type 1 or type 2 diabetes experience peripheral neuropathy—weakness, numbness, and pain, primarily in the hands and feet.  New discoveries by a team of researchers at Salk Research Institute may provide a new way to identify people at high risk for peripheral neuropathy and a potential treatment option.
Read here for more information on this study, authored by a distinguished team of researchers, including senior researcher and Diabetes Research Connection founder and board member           Nigel Calcutt.
